[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SG11201701493VA - Systems level state characteristics in experimental treatment of disease - Google Patents

Systems level state characteristics in experimental treatment of disease

Info

Publication number
SG11201701493VA
SG11201701493VA SG11201701493VA SG11201701493VA SG11201701493VA SG 11201701493V A SG11201701493V A SG 11201701493VA SG 11201701493V A SG11201701493V A SG 11201701493VA SG 11201701493V A SG11201701493V A SG 11201701493VA SG 11201701493V A SG11201701493V A SG 11201701493VA
Authority
SG
Singapore
Prior art keywords
disease
level state
state characteristics
experimental treatment
systems level
Prior art date
Application number
SG11201701493VA
Inventor
Per Fredrik Petersson
Pär Halje
Original Assignee
Per Fredrik Petersson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Per Fredrik Petersson filed Critical Per Fredrik Petersson
Publication of SG11201701493VA publication Critical patent/SG11201701493VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7282—Event detection, e.g. detecting unique waveforms indicative of a medical condition
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/369—Electroencephalography [EEG]
    • A61B5/377—Electroencephalography [EEG] using evoked responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4058—Detecting, measuring or recording for evaluating the nervous system for evaluating the central nervous system
    • A61B5/4064—Evaluating the brain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4082—Diagnosing or monitoring movement diseases, e.g. Parkinson, Huntington or Tourette
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
    • A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/725—Details of waveform analysis using specific filters therefor, e.g. Kalman or adaptive filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235—Details of waveform analysis
    • A61B5/7253—Details of waveform analysis characterised by using transforms
    • A61B5/7257—Details of waveform analysis characterised by using transforms using Fourier transforms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Neurology (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Signal Processing (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Developmental Disabilities (AREA)
  • Mathematical Physics (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Databases & Information Systems (AREA)
  • Data Mining & Analysis (AREA)
  • Business, Economics & Management (AREA)
  • General Business, Economics & Management (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
SG11201701493VA 2014-08-26 2015-08-26 Systems level state characteristics in experimental treatment of disease SG11201701493VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE1400404 2014-08-26
PCT/EP2015/069555 WO2016030424A1 (en) 2014-08-26 2015-08-26 Systems level state characteristics in experimental treatment of disease

Publications (1)

Publication Number Publication Date
SG11201701493VA true SG11201701493VA (en) 2017-03-30

Family

ID=54014810

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201701493VA SG11201701493VA (en) 2014-08-26 2015-08-26 Systems level state characteristics in experimental treatment of disease

Country Status (4)

Country Link
US (1) US20170251943A1 (en)
EP (1) EP3185749A1 (en)
SG (1) SG11201701493VA (en)
WO (1) WO2016030424A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10095837B2 (en) 2014-11-21 2018-10-09 Medtronic, Inc. Real-time phase detection of frequency band
US11291832B2 (en) * 2018-06-29 2022-04-05 Case Western Reserve University Patient-specific local field potential model
US11318296B2 (en) 2018-10-26 2022-05-03 Medtronic, Inc. Signal-based automated deep brain stimulation programming
US11045652B2 (en) 2019-04-26 2021-06-29 Medtronic, Inc. Determination of therapy electrode locations relative to oscillatory sources within patient
US11872402B2 (en) 2020-10-22 2024-01-16 Medtronic, Inc. Determining relative phase relationships for delivery of electrical stimulation therapy
CN114403899B (en) * 2022-02-08 2023-07-25 浙江浙大西投脑机智能科技有限公司 Depression detection device combining brain neuron spike potential and local field potential
CN115670390B (en) * 2022-12-30 2023-04-07 广东工业大学 Parkinson's disease axial symptom severity degree characterization method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8095210B2 (en) * 2007-01-19 2012-01-10 California Institute Of Technology Prosthetic devices and methods and systems related thereto
US20100069776A1 (en) * 2008-09-04 2010-03-18 Bradley Greger Diagnosing and monitoring neurological pathologies and states

Also Published As

Publication number Publication date
EP3185749A1 (en) 2017-07-05
US20170251943A1 (en) 2017-09-07
WO2016030424A1 (en) 2016-03-03

Similar Documents

Publication Publication Date Title
IL281793A (en) Use of cannabinoids in the treatment of epilepsy
PL3157511T3 (en) Use of cannabinoids in the treatment of epilepsy
GB2535388B (en) System of living
GB201701673D0 (en) Methods of well treatment
IL248856A0 (en) New treatment
SG11201609652RA (en) Treatment of polybacterials infections
EP3215219C0 (en) Skin treatment system
SG11201701493VA (en) Systems level state characteristics in experimental treatment of disease
PL3277280T3 (en) Isomyosmine for use in the treatment of autoimmune diseases
HK1244711A1 (en) Treatment of hmgb1-mediated inflammation
GB201416832D0 (en) Methods of treatment
EP3145931A4 (en) Treatment of autoimmune disease
GB2531635B (en) Water treatment
GB201404372D0 (en) Assay and treatment
GB201515244D0 (en) Treatment of inflammatory disease or condition
GB201412010D0 (en) Treatment of hypertransaminasemia
FI20145712A (en) Treatment of curved surfaces
GB201411027D0 (en) Treatment
GB201412411D0 (en) Treatment
GB201414023D0 (en) Treatment of autoimmune diseases
ZA201504639B (en) Treatment of water
GB201504413D0 (en) Treatment of disease
GB201413317D0 (en) Atheroscierosis treatment
GB201412410D0 (en) Treatment
GB201412441D0 (en) Treatment system